Specific differentiation of mesenchymal stem cells by small molecules

American Journal of Stem Cells

Volumn 1, Issue 1, 2012, Pages 22-30

  Song, Heesang ^a   Chang, Woochul ^b   Song, Byeong Wook ^c   Hwang, Ki Chul ^c  

^a Chosun University   (South Korea)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Cell fate; Differentiation; Mesenchymal stem cells; Small molecules

Indexed keywords

2 (2, 4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL) MALEIMIDE; ASCORBIC ACID; AZACITIDINE; DEXAMETHASONE; INDOLACTAM V; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1, 4 DIAZEPIN 1 YL) 6, 7 DIMETHOXY 4 QUINAZOLINAMINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; ROSIGLITAZONE; TRANYLCYPROMINE; UNCLASSIFIED DRUG;

ADIPOGENESIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHONDROGENESIS; HUMAN; MESENCHYMAL STEM CELL; MOLECULAR LIBRARY; NERVE CELL DIFFERENTIATION; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW;

EID: 85015296144     PISSN: None     EISSN: 21604150     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Segers VF and Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451: 937-942.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
3. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA and Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
4. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL and Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669-1675.
5. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A and Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental hematology 2002; 30: 42-48.
6. Sasaki K, Ichikawa H, Takei S, No HS, Tomotsune D, Kano Y, Yokoyama T, Sirasawa S, Mogi A, Yoshie S, Sasaki S, Yamada S, Matsumoto K, Mizuguchi M, Yue F and Tanaka Y. Hepatocyte differentiation from human ES cells using the simple embryoid body formation method and the staged-additional cocktail. TheScientificWorldJournal 2009; 9: 884-890.
7. Otsuru S, Rasini V, Bussolari R, Hofmann TJ, Dominici M and Horwitz EM. Cytokine-induced osteopoietic differentiation of transplanted marrow cells. Blood 2011;
8. Schugar RC, Robbins PD and Deasy BM. Small molecules in stem cell self-renewal and differentiation. Gene therapy 2008; 15: 126-135.
9. Feng B, Ng JH, Heng JC and Ng HH. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell stem cell 2009; 4: 301-312.
10. Li W and Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends in pharmacological sciences 2010; 31: 36-45.
11. De Bari C, Dell'Accio F, Tylzanowski P and Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and rheumatism 2001; 44: 1928-1942.
12. Barbaric I, Gokhale PJ, Jones M, Glen A, Baker D and Andrews PW. Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies. Stem cell research 2010; 5: 104-119.
13. Jagasia R, Song H, Gage FH and Lie DC. New regulators in adult neurogenesis and their potential role for repair. Trends in molecular medicine 2006; 12: 400-405.
14. Emre N, Coleman R and Ding S. A chemical approach to stem cell biology. Current opinion in chemical biology 2007; 11: 252-258.
15. Mitchison TJ. Towards a pharmacological genetics. Chemistry & biology 1994; 1: 3-6.
16. Schreiber SL. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorganic & medicinal chemistry 1998; 6: 1127-1152.
17. Barbaric I, Gokhale PJ and Andrews PW. Highcontent screening of small compounds on human embryonic stem cells. Biochemical Society transactions 2010; 38: 1046-1050.
18. Davies SP, Reddy H, Caivano M and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. The Biochemical journal 2000; 351: 95-105.
19. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR and Cohen P. The selectivity of protein kinase inhibitors: a further update. The Biochemical journal 2007; 408: 297-315.
20. Strickland S and Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 393-403.
21. Andrews PW. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Developmental biology 1984; 103: 285-293.
22. Jakob H, Dubois P, Eisen H and Jacob F. [Effects of hexamethylenebisacetamide on the differentiation of embryonal carcinoma cells]. Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles 1978; 286: 109-111.
23. Friend C, Scher W, Holland JG and Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proceedings of the National Academy of Sciences of the United States of America 1971; 68: 378-382.
24. Ding S, Wu TY, Brinker A, Peters EC, Hur W, Gray NS and Schultz PG. Synthetic small molecules that control stem cell fate. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 7632-7637.
25. Chen S, Do JT, Zhang Q, Yao S, Yan F, Peters EC, Scholer HR, Schultz PG and Ding S. Selfrenewal of embryonic stem cells by a small molecule. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 17266-17271.
26. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P and Smith A. The ground state of embryonic stem cell selfrenewal. Nature 2008; 453: 519-523.
27. Li W, Zhou H, Abujarour R, Zhu S, Young Joo J, Lin T, Hao E, Scholer HR, Hayek A and Ding S. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem cells 2009; 27: 2992-3000.
28. Zhu S, Wurdak H, Wang J, Lyssiotis CA, Peters EC, Cho CY, Wu X and Schultz PG. A small molecule primes embryonic stem cells for differentiation. Cell stem cell 2009; 4: 416-426.
29. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M and Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature biotechnology 2009; 27: 275-280.
30. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR and Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell stem cell 2008; 2: 525-528.
31. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR and Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell stem cell 2008; 3: 568-574.
32. Lee EK, Bae GU, You JS, Lee JC, Jeon YJ, Park JW, Park JH, Ahn SH, Kim YK, Choi WS, Kang JS, Han G and Han JW. Reversine increases the plasticity of lineage-committed cells toward neuroectodermal lineage. The Journal of biological chemistry 2009; 284: 2891-2901.
33. Anastasia L, Sampaolesi M, Papini N, Oleari D, Lamorte G, Tringali C, Monti E, Galli D, Tettamanti G, Cossu G and Venerando B. Reversine -treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. Cell death and differentiation 2006; 13: 2042-2051.
34. Shan SW, Tang MK, Chow PH, Maroto M, Cai DQ and Lee KK. Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types. Proteomics 2007; 7: 4303-4316.
35. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P and Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Molecular biology of the cell 2002; 13: 4279-4295.
36. Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP and Caplan AI. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Experimental cell research 1991; 195: 492-503.
37. Muraglia A, Cancedda R and Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. Journal of cell science 2000; 113 (Pt 7): 1161-1166.
38. Graf T. Differentiation plasticity of hematopoietic cells. Blood 2002; 99: 3089-3101.
39. Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C, Hewett T, Chung T, Stock W, Sher D, Weissman S, Ferrer K, Mosca J, Deans R, Moseley A and Hoffman R. Mesenchymal stem cells are capable of homing to the bone marrow of nonhuman primates following systemic infusion. Experimental hematology 2001; 29: 244-255.
40. Devine SM, Cobbs C, Jennings M, Bartholomew A and Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101: 2999-3001.
41. Ghosh-Choudhury N, Abboud SL, Mahimainathan L, Chandrasekar B and Choudhury GG. Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells. The Journal of biological chemistry 2003; 278: 21998-22005.
42. Hwang KC, Kim JY, Chang W, Kim DS, Lim S, Kang SM, Song BW, Ha HY, Huh YJ, Choi IG, Hwang DY, Song H, Jang Y, Chung N, Kim SH and Kim DW. Chemicals that modulate stem cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2008; 105: 7467-7471.
43. Jaiswal N, Haynesworth SE, Caplan AI and Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Journal of cellular biochemistry 1997; 64: 295-312.
44. Castelo-Branco G, Rawal N and Arenas E. GSK -3 inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. Journal of cell science 2004; 117: 5731-5737.
45. Augello A and De Bari C. The regulation of differentiation in mesenchymal stem cells. Human gene therapy 2010; 21: 1226-1238.
46. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A and Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. The Journal of clinical investigation 1999; 103: 697-705.
47. Fukuda K. Application of mesenchymal stem cells for the regeneration of cardiomyocyte and its use for cell transplantation therapy. Human cell: official journal of Human Cell Research Society 2003; 16: 83-94.
48. Shim WS, Jiang S, Wong P, Tan J, Chua YL, Tan YS, Sin YK, Lim CH, Chua T, Teh M, Liu TC and Sim E. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocytelike cells. Biochemical and biophysical research communications 2004; 324: 481-488.
49. Ding S and Schultz PG. A role for chemistry in stem cell biology. Nature biotechnology 2004; 22: 833-840.
50. Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C and Watt SM. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox sanguinis 2008; 95: 137-148.
51. Roura S, Farre J, Hove-Madsen L, Prat-Vidal C, Soler-Botija C, Galvez-Monton C, Vilalta M and Bayes-Genis A. Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells. Basic research in cardiology 2010; 105: 419-430.
52. Zhang W, Yan Q, Zeng YS, Zhang XB, Xiong Y, Wang JM, Chen SJ, Li Y, Bruce IC and Wu W. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain research 2010; 1359: 256-271.
53. Henderson SE, Santangelo KS and Bertone AL. Chondrogenic effects of exogenous retinoic acid or a retinoic acid receptor antagonist (LE135) on equine chondrocytes and bone marrow-derived mesenchymal stem cells in monolayer culture. American journal of veterinary research 2011; 72: 884-892.
54. Dingwall M, Marchildon F, Gunanayagam A, Louis CS and Wiper-Bergeron N. Retinoic acidinduced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells. Differentiation; research in biological diversity 2011;
55. Benvenuti S, Cellai I, Luciani P, Deledda C, Baglioni S, Giuliani C, Saccardi R, Mazzanti B, Dal Pozzo S, Mannucci E, Peri A and Serio M. Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. Journal of endocrinological investigation 2007; 30: RC26-30.
56. Muruganandan S, Parlee SD, Rourke JL, Ernst MC, Goralski KB and Sinal CJ. Chemerin, a Novel Peroxisome Proliferator-activated Receptor (PPAR) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis. The Journal of biological chemistry 2011; 286: 23982-23995.
57. Grigoriadis AE, Heersche JN and Aubin JE. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bonederived clonal cell population: effect of dexamethasone. The Journal of cell biology 1988; 106: 2139-2151.
58. Manning G, Whyte DB, Martinez R, Hunter T and Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298: 1912-1934.
59. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR and Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. The Journal of biological chemistry 2000; 275: 9645-9652.
60. Hu X, Jin L and Feng L. Erk1/2 but not PI3K pathway is required for neurotrophin 3-induced oligodendrocyte differentiation of post-natal neural stem cells. Journal of neurochemistry 2004; 90: 1339-1347.
61. Koyanagi M, Haendeler J, Badorff C, Brandes RP, Hoffmann J, Pandur P, Zeiher AM, Kuhl M and Dimmeler S. Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. The Journal of biological chemistry 2005; 280: 16838-16842.
62. Song H, Hwang HJ, Chang W, Song BW, Cha MJ, Kim IK, Lim S, Choi EJ, Ham O, Lee CY, Park JH, Lee SY, Choi E, Lee C, Lee M, Lee MH, Kim SH, Jang Y and Hwang KC. Cardiomyocytes from phorbol myristate acetateactivated mesenchymal stem cells restore electromechanical function in infarcted rat hearts. Proceedings of the National Academy of Sciences of the United States of America 2011; 108: 296-301.
63. Wu X, Ding S, Ding Q, Gray NS and Schultz PG. A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. Journal of the American Chemical Society 2002; 124: 14520-14521.
64. Sakamoto S, Kojima F, Igarashi M, Sawa R, Umekita M, Kubota Y, Nakae K, Yamaguchi S, Adachi H, Nishimura Y and Akamatsu Y. Decalpenic acid, a novel small molecule from Penicillium verruculosum CR37010, induces early osteoblastic markers in pluripotent mesenchymal cells. The Journal of antibiotics 2010; 63: 703-708.
65. Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, Cohen S, Cohen IR and Zipori D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007; 109: 1422-1432.
66. Peterson RT, Mably JD, Chen JN and Fishman MC. Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Current biology: CB 2001; 11: 1481-1491.
67. Fukuda K. Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone marrow transplantation 2003; 32 Suppl 1: S25-27.
68. Liao J, Hammerick KE, Challen GA, Goodell MA, Kasper FK and Mikos AG. Investigating the role of hematopoietic stem and progenitor cells in regulating the osteogenic differentiation of mesenchymal stem cells in vitro. Journal of orthopaedic Research: official publication of the Orthopaedic Research Society 2011;
69. Potdar PD and D'Souza SB. Ascorbic acid induces in vitro proliferation of human subcutaneous adipose tissue derived mesenchymal stem cells with upregulation of embryonic stem cell pluripotency markers Oct4 and SOX 2. Human cell: official journal of Human Cell Research Society 2010; 23: 152-155.
70. Wu X, Walker J, Zhang J, Ding S and Schultz PG. Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chemistry & biology 2004; 11: 1229-1238.